Search research articles
Contact Us
Filters
Showing results (41-50 of 348) with videos related to
Page
of 35
Sort By:
Journal of Hepato-Biliary-Pancreatic Sciences
|
March 30, 2012
Role of chemotherapy in treatments for biliary tract cancer
Junji Furuse, Akiyoshi Kasuga, Atsuko Takasu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 19, 2011
[Managements for jaundice]
Junji Furuse, Masao Toki, Hiroshi Kitamura, et al.
Plos One
|
March 8, 2024
Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan
Tatsuya Yamashita, Natsumi Suzuki, Katsuaki Motoyoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 20, 2007
[Treatments of pancreatic cancer from the standpoint of medical oncology]
Junji Furuse, Hiroshi Ishii, Kohei Nakachi, et al.
International Journal of Clinical Oncology
|
February 14, 2024
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan
Junji Furuse, Fumihiko Osugi, Koji Machii, et al.
Japanese Journal of Clinical Oncology
|
February 3, 2007
Prognostic factors in patients with gemcitabine-refractory pancreatic cancer
Kohei Nakachi, Junji Furuse, Hiroshi Ishii, et al.
Japanese Journal of Clinical Oncology
|
September 21, 2005
Primary tumor of pancreatic cancer as a measurable target lesion in chemotherapy trials
Hiroshi Ishii, Junji Furuse, Kouhei Nakachi, et al.
The Oncologist
|
December 1, 2010
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective
Alan P Venook, Christos Papandreou, Junji Furuse, et al.
Japanese Journal of Clinical Oncology
|
July 28, 2006
A phase I/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancer
Takuji Okusaka, Hiroshi Ishii, Akihiro Funakoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 23, 2015
[Chemoradiotherapy for Locally Advanced Pancreatic Cancer]
Naohiro Okano, Kirio Kawai, Daisuke Naruge, et al.
Page
of 35
Search research articles
Search
Showing results (41-50 of 348) with videos related to
Sort By:
Page
of 35
Journal of Hepato-Biliary-Pancreatic Sciences
|
March 30, 2012
Role of chemotherapy in treatments for biliary tract cancer
Junji Furuse, Akiyoshi Kasuga, Atsuko Takasu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 19, 2011
[Managements for jaundice]
Junji Furuse, Masao Toki, Hiroshi Kitamura, et al.
Plos One
|
March 8, 2024
Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan
Tatsuya Yamashita, Natsumi Suzuki, Katsuaki Motoyoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 20, 2007
[Treatments of pancreatic cancer from the standpoint of medical oncology]
Junji Furuse, Hiroshi Ishii, Kohei Nakachi, et al.
International Journal of Clinical Oncology
|
February 14, 2024
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan
Junji Furuse, Fumihiko Osugi, Koji Machii, et al.
Japanese Journal of Clinical Oncology
|
February 3, 2007
Prognostic factors in patients with gemcitabine-refractory pancreatic cancer
Kohei Nakachi, Junji Furuse, Hiroshi Ishii, et al.
Japanese Journal of Clinical Oncology
|
September 21, 2005
Primary tumor of pancreatic cancer as a measurable target lesion in chemotherapy trials
Hiroshi Ishii, Junji Furuse, Kouhei Nakachi, et al.
The Oncologist
|
December 1, 2010
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective
Alan P Venook, Christos Papandreou, Junji Furuse, et al.
Japanese Journal of Clinical Oncology
|
July 28, 2006
A phase I/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancer
Takuji Okusaka, Hiroshi Ishii, Akihiro Funakoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 23, 2015
[Chemoradiotherapy for Locally Advanced Pancreatic Cancer]
Naohiro Okano, Kirio Kawai, Daisuke Naruge, et al.
Page
of 35